tiprankstipranks
Trending News
More News >
Creo Medical Group PLC (GB:CREO)
LSE:CREO

Creo Medical (CREO) Price & Analysis

Compare
52 Followers

CREO Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

3.64%96.36%
Mutual Funds
― Other Institutional Investors
96.36% Public Companies and
Individual Investors

CREO FAQ

What was Creo Medical Group PLC’s price range in the past 12 months?
Creo Medical Group PLC lowest share price was 9.22p and its highest was 37.00p in the past 12 months.
    What is Creo Medical Group PLC’s market cap?
    Creo Medical Group PLC’s market cap is £57.75M.
      When is Creo Medical Group PLC’s upcoming earnings report date?
      Creo Medical Group PLC’s upcoming earnings report date is Oct 06, 2025 which is in 109 days.
        How were Creo Medical Group PLC’s earnings last quarter?
        Currently, no data Available
        Is Creo Medical Group PLC overvalued?
        According to Wall Street analysts Creo Medical Group PLC’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Creo Medical Group PLC pay dividends?
          Creo Medical Group PLC does not currently pay dividends.
          What is Creo Medical Group PLC’s EPS estimate?
          Creo Medical Group PLC’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Creo Medical Group PLC have?
          Creo Medical Group PLC has 412,473,330 shares outstanding.
            What happened to Creo Medical Group PLC’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Creo Medical Group PLC?
            Currently, no hedge funds are holding shares in GB:CREO

            Company Description

            Creo Medical Group PLC

            Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was incorporated in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.
            Similar Stocks
            Company
            Price & Change
            Follow
            RUA Life Sciences
            Inspiration Healthcare
            Tissue Regenix
            Belluscura PLC
            Ondine Biomedical, Inc.
            Popular Stocks
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis